Dr. Inas O. Almasry, MD

Dr. Almasry practices at Vibra Hospital of Western Massachusetts in Rochdale, Massachusetts, part of Vibra Healthcare.

Dr. Almasry's NPI, 1154310746, was assigned on October 17, 2005. Dr. Almasry holds Massachusetts license 234023.

Dr. Almasry's primary practice is Vibra Hospital of Western Massachusetts, at 111 Huntoon Memorial Highway, 1st Floor, Rochdale, MA 01542 in Worcester County. The practice phone is (413) 787-6700.

Dr. Almasry's primary practice is Vibra Hospital of Western Massachusetts in Rochdale, Massachusetts, part of Vibra Healthcare. Dr. Almasry is also affiliated with UMass Memorial Medical Center - University Campus. The medical group on file is Vibra Healthcare. Dmand AI also links Dr. Almasry to 1 more hospital, 7 medical groups, 2 group practices and clinics, 2 skilled nursing facilities and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Almasry practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Almasry's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Almasry is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Almasry's licenses on file in 2 states: Massachusetts and Illinois.

CMS data shows 287 Medicare services from Dr. Almasry across 6 procedure codes in 2024, for 109 Medicare patients. Medicare paid $19,472 for them.

CMS counts 109 Medicare patients who saw Dr. Almasry in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 69% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Almasry's median patient age at 53, with 52% women.

In 2024, Dr. Almasry wrote 11,938 Medicare Part D claims for 247 patients. 83% of them were for generic drugs. CMS names the drug for 11,284 of them, across 160 drugs with 11 or more claims each, at $689,901 in total drug cost. In 2023, CMS named 14,752 claims across 155 drugs.

Dr. Almasry accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 30 general payments to Dr. Almasry from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. ACADIA Pharmaceuticals Inc paid the most, $307.